Low molecular weight chemicals may induce occupational asthma by acting as haptens.' 2 Sterilising agents of low molecular weight containing halogens have been reported to cause occupational asthma.3 Here we report a case of occupational asthma due to inhaled hexachlorophene (molecular weight 406*9), which is used in medical practice as a powder or solution for topical disinfection. In the patient we describe asthmatic symptoms were provoked by hexachlorophene powder and the asthmatic attacks were reproduced by inhalation challenge. To obtain further information about the pathogenesis of the reaction we measured serum neutrophil chemotactic activity before and after challenge.
Low molecular weight chemicals may induce occupational asthma by acting as haptens.' 2 Sterilising agents of low molecular weight containing halogens have been reported to cause occupational asthma. 3 Here we report a case of occupational asthma due to inhaled hexachlorophene (molecular weight 406*9), which is used in medical practice as a powder or solution for topical disinfection. In the patient we describe asthmatic symptoms were provoked by hexachlorophene powder and the asthmatic attacks were reproduced by inhalation challenge. To obtain further information about the pathogenesis of the reaction we measured serum neutrophil chemotactic activity before and after challenge.
Case report and invesIptions
The patient was a 43 year old children's nurse who had been working in contact with hexachlorophene for 15 years. She had had respiratory symptoms for about 10 years. Initially her symptoms were of rhinitis but for the last two years she had had frequent attacks of asthma, which were sometimes very severe. She had noticed that her symptoms of chest tightness and breathlessness began some minutes after starting work with hexachlorophene and that she was free of symptoms at weekends and while on holiday. She smoked four cigarettes daily. She was non-atopic as judged by negative skinprick test responses to common allergens and a total serum IgE level of 73 U/mi as measured by the PRIST technique (Phadebas). Skin testing with a 1% solution of hexachlorophene also produced a negative result; the blood eosinophil count was normal. The results of routine blood tests and the chest radiograph were normal. Non-specific bronchial reactivity to five breaths of acetylcholine (100 ,ug/ml) inhaled from an ultrasonic nebuliser was shown to be increased.
Inhalation challenge tests using the technique of Pepys and Hutchcroft' were performed, airways resistance being measured in a constant volume whole body plethysmograph. On three separate occasions the patient inhaled undiluted hexachlorophene powder for 20 minutes and on a subsequent occasion the test was repeated 20 minutes after inhalation of 40 mg sodium cromoglycate. On other days we assessed the spontaneous diurnal variation in airway resistances and, as a control, an inhalation challenge was performed with lactose in double blind fashion. We also performed an inhalation challenge with hexachlorophene in an asthmatic who had not previously been exposed. Address group.bmj.com on June 22, 2017 -Published by http://thorax.bmj.com/ Downloaded from challenges, together with changes in neutrophil chemotactic activity after hexachlorophene challenge. On the control day there was the expected rise in airways resistance in the early morning and this was similar on the hexachlorophene day. In addition, after exposure to hexachlorophene, but not to lactose, there was an immediate asthmatic reaction, which mimicked the subjects's usual symptoms and was reproducible on the different study days. The rise in airways resistance was mirrored by a corresponding rise in neutrophil chemotactic activity. After pretreatment with sodium chromoglycate (fig 2) the immediate rise in both airways resistance and neutrophil chemotactic activity was abolished. The late rise in airways resistance was similar to that on the control days and was attributable to spontaneous diurnal variation.
The non-exposed asthmatic subject we studied had a similar degree of hyperreactivity to acetylcholine as our patient and did not react to bronchial challenge with hexachlorophene.
Discussion
We have described occupational asthma due to hexachlorophene in a children' s nurse. This agent is widely used as a topical disinfectant but other similarly exposed nurses had no significant respiratory symptoms. In such cases it is important to take account of circadian variation in airway function,5 which accounted for the apparent late reaction in our case. The immediate airway reaction was blocked by pretreatment with sodium cromoglycate and this, together with the demonstrated increase in neutrophil chemotactic activity, which was also blocked by sodium cromoglycate, suggests that the mechanism may be mast cell dependent. One other asthmatic subject showed no evidence of asthma 631 provoked by hexachlorophene when similarly challenged. We do not, however, have any information on neutrophil chemotactic activity in non-exposed asthmatic subjects after challenge or in non-asthmatic normal subjects regularly exposed to hexachlorophehe.
Hexachlorophene is in frequent use in hospitals as an antiseptic in both lotion and powder form. The powder has the theoretical advantage of achieving a similar antiseptic effect with less skin absorption but the findings in the patient described here suggest that this needs to be balanced against its possible role as a cause of occupational asthma.
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